Quantcast
Last updated on April 18, 2014 at 8:18 EDT

Latest Histopathology Stories

2009-11-09 07:00:00

WESTMONT, Ill., Nov. 9 /PRNewswire/ -- Prostate cancer is the second most common cancer in American men. One in six men will be diagnosed during his lifetime, according to the American Cancer Society. In its continuing efforts to share information about this prevalent disease, the world-renowned Chicago Prostate Cancer Center has developed a complimentary 22-page guide and DVD to anyone interested in learning more about prostate cancer. The full-color, spiral-bound guide includes:...

2009-08-27 15:01:00

SAN DIEGO, Aug. 27 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the Company has begun a clinical trial intended to secure U.S. regulatory approval of its PROGENSA(R) PCA3 assay, a new molecular test that may help determine the need for a repeat prostate biopsy. "Based on the results of our extensive clinical research studies and our European commercial experience, we believe that our PROGENSA PCA3 assay can help predict the risk of a positive...

2009-07-15 08:12:50

Immunotherapy targets Alzheimer's tau tangles and more doctors are diagnosing and treating mild cognitive impairmentNew insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins "“ beta amyloid and phosphorylated tau "“ that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna.Scientists also reported on how clinicians view...

2009-07-15 01:30:00

VIENNA, July 15 /PRNewswire-USNewswire/ -- New insights into how a Phase III Alzheimer's drug might work were among the advances in potential therapies targeting two abnormal brain proteins - beta amyloid and phosphorylated tau - that were reported today at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna. (Logo: http://www.newscom.com/cgi-bin/prnh/20090529/ICADLOGO ) Scientists also reported on how clinicians view and treat mild...

2009-06-15 11:21:09

A new study shows that a radioactive skin patch can safely and successfully treat basal cell carcinoma, one of the most common types of skin cancers, according to researchers at the SNM's 56th Annual Meeting. The skin patch, which delivers the radioactive phosphorus-32, is nontoxic and could be an excellent alternative to surgery or radiotherapy in cases where carrying out these treatments is difficult."While basal cell carcinoma is rarely fatal, it can be a painful and disfiguring disease,"...

2009-05-27 17:54:00

Data show superiority of endoscopic ablation therapy using the HALO System for eradicating Barrett's esophagus in randomized, multicenter, sham controlled trial SUNNYVALE, Calif., May 27 /PRNewswire/ -- Results from a clinical study published today in the New England Journal of Medicine reveal that ablative therapy using the HALO system (BARRX Medical, Inc.) is highly effective for complete eradication of a pre-cancerous condition of the esophagus called Barrett's esophagus afflicting more...

2009-04-29 15:01:00

- Eight Studies Presented at Leading Urology Meeting Show that Simple Urine Test for PCA3 Gene May Improve Accuracy of Prostate Cancer Detection, Reduce Unnecessary Biopsies - - Gen-Probe to Begin Pivotal Clinical Study in Effort to Gain U.S. Regulatory Approval - SAN DIEGO, April 29 /PRNewswire-FirstCall/ -- Eight studies presented this week at the annual meeting of the American Urological Association (AUA) suggest that Gen-Probe's (Nasdaq: GPRO) investigational test for the highly...

2009-04-27 06:55:00

The combination therapy of vitamin E, selenium and soy does not prevent the progression from high-grade prostatic intraepithelial neoplasia (HGPIN) to prostate cancer, according to the new research presented at the 104th Annual Scientific Meeting of the American Urological Association (AUA). The study confirms the findings of the Selenium and Vitamin E Cancer Prevention Trial (SELECT) and expands knowledge of the affect soy has on prostate cancer. Canadian researchers divided 303 men, with an...

2009-02-26 11:14:35

A new study suggests that the metabolic response to obesity and insulin resistance, particularly as it pertains to the liver, differs among ethnic groups in the U.S. African-Americans are more resistant to the buildup of fat in the abdominal adipose tissue and liver, and to high triglyceride levels associated with insulin resistance. These findings are in the March issue of Hepatology, a journal published by John Wiley & Sons on behalf of the American Association for the Study of Liver...

2009-02-13 16:46:11

Diets rich in omega-3 fatty acids -- from salmon and sardines -- protect the liver from damage and insulin resistance, Spanish researchers said. Joan Claria of the University of Barcelona found that two types of lipids in omega-3 fatty acids -- protectins and resolvins -- were the cause of the protective effect. They studied four groups of mice with an altered gene making them obese and diabetic. One group was given an omega-3-enriched diet and the second group was given a control diet. The...